Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Urica Therapeutics
Miami, Florida, United Statesuricatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Completed Phase 1 trial in healthy volunteers in the US showing comparable pharmacokinetic, pharmacodynamic and safety profile between US and Japanese subjects. Initiated Phase 1b clinical trial in gout patients in the US with plans to begin pivotal clinical trials in 2024[4].
- Therapeutic areas
- NephrologyMetabolic DisordersRheumatology
- Modalities
- Small molecules
- Industry
- Biotech
02
Partnerships
Fuji Yakuhin Co. Ltd.
Beyond the preview
Go deeper on Urica Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Urica Therapeutics.